Phase-transition nanodroplets with immunomodulatory capabilities for potentiating mild magnetic hyperthermia to inhibit tumour proliferation and metastasis

BACKGROUND: Magnetic hyperthermia (MHT)-mediated thermal ablation therapy has promising clinical applications in destroying primary tumours. However, traditional MHT still presents the challenges of damage to normal tissues adjacent to the treatment site and the destruction of tumour-associated anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Qiaoxi, Zhou, Yang, Li, Pan, Liu, Ying, Deng, Ruxi, Tang, Rui, Wu, Nianhong, Wan, Li, Ye, Ming, Zhou, Hong, Wang, Zhiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108485/
https://www.ncbi.nlm.nih.gov/pubmed/37069614
http://dx.doi.org/10.1186/s12951-023-01885-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10108485/
https://www.ncbi.nlm.nih.gov/pubmed/37069614
http://dx.doi.org/10.1186/s12951-023-01885-4

Ejemplares similares